Myers Cocktail IV Therapy: A Physician's Guide to Nutrients, Benefits & Who It's For

At a Glance

The Myers Cocktail occupies a unique position in integrative medicine: it has been in clinical use for over six decades, yet it remains one of the most debated IV therapies among conventional practitioners. In my clinical experience, this gap between skepticism and widespread patient response says less about the therapy itself and more about the limits of oral micronutrient dosing.

Developed by Baltimore physician John Myers in the 1960s and later popularized by Alan Gaby M.D., the formulation works from a straightforward premise—certain nutrients have dose-dependent effects on cellular energy production, neuromuscular function, and immune regulation, and the gastrointestinal tract imposes hard ceilings on how much can be absorbed. Intravenous delivery removes that ceiling entirely.

This guide covers what is actually in the Myers Cocktail, what the science shows, who tends to benefit most, how infusion protocols differ across clinics, and what patients should realistically expect.

What Is the Myers Cocktail? Composition and Rationale

The original Myers formulation is not a proprietary product—it is a physician-compounded blend that any licensed clinic can prepare. The standard components are:

• Magnesium chloride or magnesium sulfate (1–5 g) — involved in over 300 enzymatic reactions, critical for ATP synthesis and smooth muscle relaxation
• B-complex vitamins (B1/thiamine, B2/riboflavin, B3/niacin, B5/pantothenic acid, B6/pyridoxine) — cofactors in mitochondrial energy pathways including the Krebs cycle
• Vitamin B12 (hydroxocobalamin or methylcobalamin, 1–5 mg) — essential for neurological function, myelin integrity, and red blood cell production
• Calcium gluconate (1–2 g) — included partly to balance magnesium’s vasodilatory effect and support neuromuscular signaling
• Vitamin C (1–25 g depending on the clinic and indication) — antioxidant, collagen synthesis cofactor, and immune modulator at high doses

Some clinics add additional components: glutathione, zinc, selenium, B7 (biotin), or amino acids. Strictly speaking, these are extensions of the original formula rather than the classical Myers Cocktail.

Why IV Delivery Matters

Oral magnesium is limited to roughly 30–40% absorption under ideal conditions, and higher doses trigger diarrhea before therapeutic tissue levels are reached. Vitamin C absorption is similarly capped: oral doses above 1 g are largely excreted in urine, while intravenous doses of 10–25 g reliably achieve plasma concentrations 50–70 times higher. This distinction is not semantic—it determines whether a nutrient reaches concentrations required for pharmacological effects at the tissue level.

What the Evidence Shows

The evidence base for the Myers Cocktail is better than its critics often acknowledge, though it falls short of the large RCTs that define pharmaceutical approval.

Fibromyalgia

A 2009 randomized, double-blind, placebo-controlled trial by Massey et al. (Journal of Alternative and Complementary Medicine) enrolled 34 fibromyalgia patients. Those receiving weekly Myers infusions over 8 weeks showed significant improvements in tender point count, pain scores, depression, and quality of life versus placebo. Effect sizes were clinically meaningful, not merely statistically significant.

Chronic Fatigue

Alan Gaby’s published case series of over 1,000 patients treated over 25 years reported consistent symptomatic improvement in patients with chronic fatigue syndrome. While observational data carries obvious limitations, the magnitude and consistency of responses across diverse patient populations is difficult to attribute entirely to placebo effect.

Migraines and Tension Headaches

Magnesium deficiency is documented in 50% of migraine sufferers during acute attacks. Intravenous magnesium has been studied in over a dozen trials for acute migraine and is included in several neurology society treatment protocols. The Myers Cocktail leverages this effect in the context of comprehensive nutrient repletion—in patients with chronic migraine who also have fatigue or other deficiency-related symptoms, the broader formula appears to outperform magnesium alone.

Acute Viral Illness and Immune Support

High-dose intravenous vitamin C has the strongest mechanistic rationale here: at plasma levels above 200 mg/dL, it generates hydrogen peroxide selectively toxic to infected and metabolically stressed cells. Evidence from the COVID-19 pandemic period—including a Chinese randomized trial (ZhiYong Peng, 2020) and multiple observational studies—suggests IV vitamin C reduces ICU duration in critically ill patients. The modified Myers Cocktail (with higher vitamin C doses of 10–25 g) represents a practical clinic-based version of this protocol.

Asthma

A randomized trial found intravenous magnesium significantly reduced bronchospasm in acute asthma, an effect that has been replicated and adopted into emergency medicine practice. The Myers formulation extends this via the additional B vitamins that support cellular respiration and reduce oxidative stress in airway tissue.

Who Benefits Most: Clinical Indications

Based on published evidence and clinical experience, the Myers Cocktail shows the most consistent benefit in the following patient groups:

Chronic fatigue and post-viral syndromes. Patients who were functioning well before a triggering illness—Epstein-Barr virus, COVID-19, Lyme disease, or influenza—and have not recovered baseline energy typically have measurable deficiencies in magnesium, B12, and vitamin C. IV repletion often produces a more rapid clinical response than months of oral supplementation.

Fibromyalgia and myofascial pain. The combination of magnesium’s muscle-relaxing properties, B vitamins’ role in nerve conduction, and vitamin C’s anti-inflammatory effects addresses several overlapping mechanisms simultaneously. I typically recommend a 6–8 week course of weekly infusions before assessing response.

Chronic migraines. Patients who have failed standard preventive medications and have documented magnesium deficiency (serum or red blood cell magnesium) are good candidates. Many can reduce infusion frequency once headache patterns stabilize.

Athletes and physical recovery. High-intensity training depletes magnesium and B vitamins through sweat loss and elevated metabolic demand. A Myers infusion 24–48 hours before competition or after a heavy training block supports faster recovery without anabolic risk.

Immune support during viral illness. Initiated at the first sign of acute illness, a high-dose modified Myers (vitamin C 10–25 g) can meaningfully shorten duration and severity—consistent with data from influenza, upper respiratory infections, and COVID-19.

Pre- and post-surgical optimization. Patients preparing for elective surgery benefit from nutrient repletion to support healing; those recovering from major procedures often have significant post-operative deficiencies.

What to Expect: The Infusion Experience

Before the Infusion

A clinical assessment should precede the first infusion. In my practice this includes at minimum: serum magnesium, RBC magnesium (more sensitive), B12 with methylmalonic acid, complete blood count, and basic metabolic panel. G6PD deficiency must be excluded before high-dose vitamin C (doses above 10 g), as it can trigger hemolysis in affected individuals.

Patients should eat a light meal 1–2 hours before and arrive well hydrated—dehydration slows infusion rate and increases the likelihood of minor side effects.

During the Infusion

The IV is placed in a peripheral vein, typically the antecubital fossa. Infusion rates are kept deliberately slow: the standard 30–60 minute duration prevents the “magnesium rush”—a sensation of warmth, flushing, or dizziness that occurs when serum magnesium rises too quickly. Patients describe this as unpleasant but not dangerous; slowing the drip resolves it within minutes.

Most patients feel relaxed during the infusion and notice what many describe as a “grounding” sensation as magnesium takes effect. Some experience mild fatigue immediately afterward; others feel noticeably energized. The full response generally develops over 12–48 hours.

Side Effects and Contraindications

Serious adverse events are rare when the protocol is followed correctly. The most common side effects are:

• Warmth or flushing during infusion (magnesium effect, rate-dependent)
• Mild lightheadedness or hypotension, particularly in volume-depleted patients
• Vein irritation at the infusion site
• Taste of vitamins during infusion (harmless)

Contraindications include: renal failure (impaired magnesium excretion), active kidney stones (calcium), G6PD deficiency with high-dose vitamin C, and severe cardiac arrhythmias in which magnesium management requires careful monitoring.

How the Myers Cocktail Compares to Other IV Protocols

The Myers Cocktail is often the entry point for patients new to IV therapy, and it serves as a useful reference when comparing other options:

Myers vs. high-dose vitamin C alone. The Myers Cocktail uses vitamin C primarily as an antioxidant and immune support at relatively modest doses (1–10 g typical). Standalone high-dose IV vitamin C protocols (25–75 g) are used for oncology support, severe infections, or post-viral syndromes where maximum plasma levels are the goal. They are more potent but also longer, more expensive, and require G6PD screening.

Myers vs. NAD+ IV. NAD+ infusions target cellular energy production through a different mechanism—replenishing the NAD coenzyme that declines with age and illness. NAD+ produces more intense neurological and energetic effects and is used for addiction recovery, neurological syndromes, and anti-aging protocols. Many patients benefit from both in combination, cycling Myers for nutrient repletion and NAD+ for deeper mitochondrial support.

Myers vs. IV glutathione. Intravenous glutathione serves as the body’s master antioxidant and detoxification agent. It is often added as a push at the end of a Myers infusion. Standalone glutathione protocols are used for heavy metal detoxification support, liver disease, and neurological conditions such as Parkinson’s disease.

Myers vs. ozone autohemotherapy. Ozone IV therapy operates through a pro-oxidant mechanism that activates endogenous antioxidant systems and disrupts microbial membranes. These are complementary rather than competing approaches—many patients with chronic infections alternate between Myers infusions and ozone depending on their phase of treatment.

Dosing Frequency and Treatment Protocols

There is no single universally correct dosing schedule; the appropriate frequency depends on indication and individual response.

Acute illness protocol: Daily or every-other-day infusions for 3–5 days during the acute phase, then reassess.

Chronic fatigue or fibromyalgia: Weekly infusions for 6–8 weeks as an induction phase, followed by biweekly or monthly maintenance based on clinical response. Some patients find that a quarterly infusion sustains their gains indefinitely; others require monthly maintenance for years.

Preventive or optimization use: Monthly infusions align with most patients’ schedules and budget constraints. Athletes may prefer strategic timing around competition or high-training blocks.

Post-viral recovery (long COVID, post-Lyme): I typically recommend weekly infusions for the first 4 weeks, with concurrent oral supplementation to bridge between sessions. The goal is to rebuild intracellular stores systematically rather than produce a transient spike in circulating levels.

Related Articles

• NAD+ IV Therapy: What to Expect and How It Works
• Intravenous Vitamin C: Clinical Evidence and Dosing
• IV Glutathione: Detoxification and Neurological Support
• Ozone vs. IV Laser Therapy: Which Protocol Fits Your Case
• Post-COVID Recovery Protocol: A Physician’s Approach

References

1. Massey PB. Reduction of fibromyalgia symptoms through intravenous nutrient therapy: results of a pilot clinical trial. Altern Ther Health Med. 2007;13(3):32-34.
2. Gaby AR. Intravenous nutrient therapy: the “Myers’ cocktail.” Altern Med Rev. 2002;7(5):389-403. PMID: 12410623.
3. Severance HW Jr, Holt T, Patrone NA, Chapman L. Profound hypomagnesemia and cardiovascular collapse after massive intravenous replacement. South Med J. 1988;81(10):1291-1292.
4. Peng Z, Zhao Z, Wannemuehler KA, et al. Effects of high-dose vitamin C on critically ill patients: systematic review and meta-analysis. Crit Care Med. 2020;48(11):e998-e1007. PMID: 32931184.
5. Altura BM, Altura BT. Magnesium and cardiovascular biology: an important link between cardiovascular risk factors and atherogenesis. Cell Mol Biol Res. 1995;41(5):347-359. PMID: 8867947.
6. Mauskop A, Altura BM. Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci. 1998;5(1):24-27. PMID: 9523054.
7. Lipton RB, Gobel H, Einhäupl KM, Wilks K, Mauskop A. Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology. 2004;63(12):2240-2244.